Drug Database
Back to search

Poland· PL-100491692

Pomalidomide Viatris

A pomalidomide product containing pomalidomidum, registered in Poland by Viatris Ltd. The same ATC class is registered in 17 of our 19 countries.

ATC L04AX06

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedPomalidomide ViatrisATCL04AX06REGISTER NO.PL-100491692PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pomalidomidumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pomalidomide is registered in 17 of 19 countries.

Countries holding a registration under ATC L04AX06 (pomalidomide), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search pomalidomide products by name

Pomalidomide · ATC L04AX06

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pomalidomide costs, country by country.

Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Pomalidomide · price per daily dose (3 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$255.48
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Pomalidomidum
Manufacturer
Viatris Ltd
Country
Poland (PL)
ATC code
L04AX06
ATC class
Pomalidomide
Defined daily dose
3 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05901797711221
  • gtin
    05901797711238

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

277 interactions on record for pomalidomide.

Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pomalidomide against other medicinesHow interaction checks work

Pomalidomide · interactions on record

277 records

  • 64 severe
  • 213 moderate

Most severe, free to view

  • ErythropoietinB03XA01severe
  • Darbepoetin alfaB03XA02severe
  • PeginesatideB03XA04severe
  • C1-inhibitor, plasma derivedB06AC01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under L04AX06

Pomalidomide, as other registers publish it.

All pomalidomide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/006c894b-fc64-44f7-b4f9-4276287f4868
GET /v1/drugs/006c894b-fc64-44f7-b4f9-4276287f4868?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "2 mg",
  "packaging": "Rpz ¦ EU/1/23/1785/006 ¦ 152658\n14 kaps. (14 x 1)\n05901797711221 ¦ Rpz ¦ EU/1/23/1785/005 ¦ 152659\n14 kaps.\n05901797711238 ¦ Rpz ¦ EU/1/23/1785/007 ¦ 152660\n21 kaps.\nRpz ¦ EU/1/23/1785/008 ¦ 152661\n21 kaps. (21 x 1)",
  "substance": "Pomalidomidum 2 mg",
  "common_name": "Pomalidomidum",
  "pl_product_id": "100491692",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about pomalidomide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console